amantadine has been researched along with glutamic acid in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Feuerstein, TJ; Jackisch, R; Koch, R; Lücking, CH; Lupp, A | 1 |
| Zídek, Z | 1 |
| Kornhuber, J; Weller, M | 1 |
| Finiels-Marlier, F; Paul, SM; Weller, M | 1 |
| Eckert, J; Fritze, J; Northoff, G | 1 |
| Blanchet, PJ; Chase, TN; Del Dotto, P; van den Munckhof, P; Verhagen Metman, L | 1 |
| Funatsuka, M; Katsumori, H; Oguni, H; Osawa, M; Sone, K; Tanaka, T | 1 |
| Blanchet, PJ; Chase, TN; Metman, LV | 1 |
| Bernardini, S; Bonuccelli, U; Del Dotto, P; Dell' Agnello, G; Gambaccini, G; Lucetti, C; Murri, L; Rossi, G | 1 |
| Inomata, S; Kakiuchi, Y; Kohda, Y; Miyabe, M; Ohara, Y; Osaka, Y; Sukegawa, I; Toyooka, H | 1 |
| Arndt, T; Heimeroth, A; John, D; Mueller, HH; Oertel, WH; Reis, J; Rosenow, F | 1 |
| Owen, JC; Whitton, PS | 1 |
| Howland, RH | 1 |
| Cao, J; Li, YP; Li, ZR; Tao, YJ | 1 |
| Egashira, N; Egawa, T; Fujiwara, M; Irie, K; Iwasaki, K; Katsurabayashi, S; Kitamura, Y; Koushi, E; Mishima, K; Nishimura, R; Orito, K; Sano, K; Takasaki, K; Uchida, N | 1 |
| Egashira, N; Fujiwara, M; Harada, S; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Oishi, R; Okuno, R | 1 |
| Akinyemi, A; Michel, G; Sanchez-Gonzalez, MA; Sterkel, S | 1 |
| Li, Q; Wang, H; Xiao, X; Zhang, H; Zhang, T | 1 |
| Garg, C; Garg, M; Walia, V | 1 |
| Ahmed, AS; Hantash, EM; Zakaria, SS | 1 |
| Maratha, S; Sharma, V; Walia, V | 1 |
3 review(s) available for amantadine and glutamic acid
| Article | Year |
|---|---|
Amantadine and other antiglutamate agents: management of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Glutamic Acid; Humans; Parkinson Disease; Psychomotor Performance; Randomized Controlled Trials as Topic | 2002 |
Renaissance of amantadine in the treatment of Parkinson's disease.
Topics: Amantadine; Animals; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Glutamic Acid; Humans; Levodopa; Parkinson Disease; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2003 |
Glutamate-modulating drugs & the treatment of mental disorders.
Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines | 2007 |
2 trial(s) available for amantadine and glutamic acid
| Article | Year |
|---|---|
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study.
Topics: Administration, Oral; Aged; Amantadine; Cross-Over Studies; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Huntington Disease; Infusions, Intravenous; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Severity of Illness Index; Treatment Outcome | 2003 |
Modulation of human motor cortex excitability by single doses of amantadine.
Topics: Adult; Amantadine; Antiparkinson Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Efferent Pathways; Electromyography; Evoked Potentials, Motor; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Motor Cortex; Muscle, Skeletal; Neural Inhibition; Neural Pathways; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Transcranial Magnetic Stimulation | 2006 |
18 other study(ies) available for amantadine and glutamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
Topics: Acetylcholine; Amantadine; Animals; Caudate Nucleus; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Female; Glutamates; Glutamic Acid; In Vitro Techniques; Magnesium; Male; Memantine; N-Methylaspartate; Rabbits; Receptors, N-Methyl-D-Aspartate; Tetrodotoxin; Tritium | 1992 |
Immune-related edemagenic activity of glutamines and glutamic acid, components of immunomodulatory agents.
Topics: Adjuvants, Immunologic; Amantadine; Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Dipeptides; Edema; Female; Glutamic Acid; Glutamine; Hemolytic Plaque Technique; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Structure-Activity Relationship | 1994 |
Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antipsychotic Agents; Depressive Disorder; Female; Glutamates; Glutamic Acid; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Schizophrenia; Schizophrenic Psychology | 1993 |
NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine.
Topics: Amantadine; Animals; Cell Survival; Cells, Cultured; Cerebellum; Cerebral Cortex; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Memantine; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1993 |
Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.
Topics: Adult; Amantadine; Catatonia; Glutamic Acid; Humans; Infusions, Intravenous; Male; N-Methylaspartate | 1997 |
Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease.
Topics: Amantadine; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Dextromethorphan; Dextrorphan; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Levodopa; Movement Disorders; Parkinson Disease; Psychomotor Performance; Receptors, N-Methyl-D-Aspartate | 1998 |
Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood.
Topics: Adult; Amantadine; Dopamine Agents; Female; Glutamic Acid; Hemiplegia; Humans; Infant; Male; Receptors, N-Methyl-D-Aspartate; Recurrence; Seizures; Treatment Outcome | 2000 |
Combined therapy with clonidine and amantadine may act in two stages of glutamate-mediated neuropathic pain caused by a needle puncture in an upper extremity.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Analgesics, Non-Narcotic; Calcium Channel Blockers; Catheterization, Peripheral; Clonidine; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Ketamine; Median Nerve; Pain; Peripheral Nervous System Diseases; Receptors, N-Methyl-D-Aspartate | 2005 |
Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving rats.
Topics: Amantadine; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Dopamine; Drug Interactions; Excitatory Amino Acid Antagonists; Extracellular Fluid; Frontal Lobe; Glutamic Acid; Male; Microdialysis; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Up-Regulation | 2006 |
[Synthesis and neuroprotective activity in cell culture of aminoadamantane analogues].
Topics: Amantadine; Cell Death; Cell Line, Tumor; Glutamic Acid; Humans; L-Lactate Dehydrogenase; Memantine; Neuroblastoma; Neuroprotective Agents | 2007 |
Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Topics: Acoustic Stimulation; Amantadine; Animals; Catalepsy; Dizocilpine Maleate; Dopamine Agents; Dronabinol; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; Hallucinogens; Male; Microinjections; Neurons; Nucleus Accumbens; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Rimonabant; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission | 2008 |
Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
Topics: Acoustic Stimulation; Amantadine; Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Memantine; Mice; Mice, Inbred ICR; Motor Activity; Obsessive-Compulsive Disorder; Quinoxalines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Riluzole | 2008 |
Preserving brain function in a comatose patient with septic hyperpyrexia (41.6 °C): a case report.
Topics: Adult; Amantadine; Anticonvulsants; Brain; Brain Injuries; Cognition Disorders; Coma; Dopamine Agents; Drug Therapy, Combination; Glutamic Acid; Humans; Levetiracetam; Male; Malignant Hyperthermia; Piracetam; Tomography, X-Ray Computed | 2017 |
Neuroprotective effect of amantadine on corticosterone-induced abnormal glutamatergic synaptic transmission of CA3-CA1 pathway in rat's hippocampal slices.
Topics: Amantadine; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Calcium; Catalase; Cations, Divalent; Cells, Cultured; Corticosterone; Glutamic Acid; Male; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Rats, Wistar; Superoxide Dismutase; Synaptic Transmission; Tissue Culture Techniques | 2017 |
Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways.
Topics: Amantadine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Diazepam; Disease Models, Animal; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Nitric Oxide; Nitrites; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2020 |
Potential of Amantadine to Ameliorate Glutamate-Induced Pyramidal Cells Toxicity in Juvenile Rat' Brain Cortex.
Topics: Age Factors; Amantadine; Animals; Animals, Newborn; Cerebral Cortex; Dopamine Agents; Glutamic Acid; Protein Phosphatase 2; Pyramidal Cells; Rats; Rats, Wistar | 2021 |
Possible involvement of NO-cGMP signaling in the antidepressant like Effect of Amantadine in mice.
Topics: Amantadine; Animals; Antidepressive Agents; Cyclic GMP; Depression; Glutamic Acid; Hindlimb Suspension; Mice; Nitric Oxide; Nitrites; Serotonin; Swimming | 2022 |